Strongbridge Biopharma plc News
Xeris Jumps on FDA Clearance of Hypoglycemia Treatment
Xeris's treatment for hypoglycemia is cleared for use in people ages 2 and over. The stock is higher.
5 Top Stock Gainers for Monday: Virgin Galactic, Beyond Meat, Tesla
Virgin Galactic, Beyond Meat, Tesla, Strongbridge Biopharma and MMA Capital Holdings are five top stock gainers for Monday.
NGM Biopharma Down; Ends Development of Liver-Disease Drug
NGM Biopharma slumped after it ended development of a drug to treat a vicious liver disease. The drug missed its goals in a study.
Xeris Pharmaceuticals to Buy Strongbridge Biopharma for $267 Million
Xeris will pay for Strongbridge with stock and contingent value rights, with the resulting company being owned 60% by current Xeris shareholders.
Perrigo, Taro Show Perils of Failure to Branch in Branded Drugs
The latest earnings from two of the largest generic drug makers show how important it is for generic firms to have their own stable of higher-margin branded products.
Take a Look at These Stocks Poised to Trade Higher
These 5 stocks under $10 look poised to potentially trade higher.
These 5 stocks under $10 could explode higher soon
Here's a technical look at how to trade several under-$10 stocks triggering breakout trades.
Chiasma plunges after FDA rejects application for growth disorder drug
Shares of Chiasma are plunging this morning after the company said the FDA rejected the company's application for approval of a proposed treatment of adult patients with a growth disorder.
'Big Short' Burry Warns That a Repeat of the 2008 Crisis Is in Sight
The legendary financier reiterates his warnings of a market collapse on the way.
McDonald's Menu Adds a (Very) New Take on an Old Favorite
The fast-food giant has been hesitant to make changes like this, but Wendy's bold move may have forced it to.
Everything Elon Musk Said At Tesla AI Day to Sell His Vision
The billionaire wants to create a "future of abundance" by mass-producing humanoid robots.